| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.1M | +271.4% |
| Cost of Revenue | $3.6M | +261.3% |
| Gross Profit | $1.5M | +298.1% |
| R&D Expense | $1.9M | +48.7% |
| SG&A Expense | $2.4M | +96.5% |
| Operating Income | -$8.1M | -33.1% |
| Net Income | -$8.5M | -29.5% |
| EPS (Basic) | -$0.55 | -22.2% |
| EPS (Diluted) | -$0.55 | -22.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.5M | — |
| Accounts Receivable | $874K | +345.9% |
| Inventory | $304K | +22.1% |
| Current Assets | $9.8M | +1735.0% |
| Total Assets | $10.1M | +1545.9% |
| Current Liabilities | $1.2M | +8.4% |
| Total Liabilities | $1.2M | +8.4% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.9M | -111.1% |
| Capital Expenditures | $315K | +1066.7% |
| Investing Cash Flow | -$315K | -1066.7% |
| Financing Cash Flow | $15.6M | +2382.2% |
| Free Cash Flow | -$7.2M | -118.9% |
| $8.9M |
| +1871.4% |